Meridian Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Meridian Wealth Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $45,679 - $53,507	772 New	772 $46,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $54,914 - $59,801	-887 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $22,964 - $25,828	387 Added 77.4%	887 $56,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $3,868 - $4,383	67 Added 15.47%	500 $31,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $5,226 - $5,791	91 Added 26.61%	433 $26,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $18,748 - $21,918	342 New	342 $20,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $16,796 - $24,409	-362 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $17,814 - $23,236	362 New	362 $23,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Meridian Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Partners, LLC with notifications on news.